Goldman Sachs Maintains Neutral on Baxter International, Raises Price Target to $21
Baxter International Inc.
Baxter International Inc. BAX | 0.00 |
Goldman Sachs analyst David Roman maintains Baxter International (NYSE:
BAX) with a Neutral and raises the price target from $19 to $21.
